{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:57:36Z","timestamp":1793933856854,"version":"4.8.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jrnjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1053\/j.jrn.2026.03.003","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:19:08Z","timestamp":1774311548000},"page":"748-757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association of C-Reactive Protein\u2013Triglyceride Glucose Index With Chronic Kidney Disease and Reduction of Renal Function"],"prefix":"10.1053","volume":"36","author":[{"given":"Wenjing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchun","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2026.03.003_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41581-020-0268-7","article-title":"The impact of chronic kidney disease on global health","volume":"16","author":"Carney","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1053\/j.jrn.2026.03.003_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"The Lancet"},{"key":"10.1053\/j.jrn.2026.03.003_bib3","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1681\/ASN.2016050562","article-title":"Global cardiovascular and renal outcomes of reduced GFR","volume":"28","author":"Thomas","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2026.03.003_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41581-023-00747-4","article-title":"Diagnosis of cardiovascular disease in patients with chronic kidney disease","volume":"19","author":"Zoccali","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1053\/j.jrn.2026.03.003_bib5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"10.1053\/j.jrn.2026.03.003_bib6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamainternmed.2022.6817","article-title":"Prevalence of chronic kidney disease in China: Results From the Sixth China Chronic Disease and Risk Factor Surveillance","volume":"183","author":"Wang","year":"2023","journal-title":"JAMA Intern Med"},{"key":"10.1053\/j.jrn.2026.03.003_bib7","first-page":"1","article-title":"Insulin resistance in patients with chronic kidney disease","volume":"2012","author":"Liao","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"10.1053\/j.jrn.2026.03.003_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4093\/dmj.2021.0280","article-title":"Insulin resistance: from mechanisms to therapeutic strategies","volume":"46","author":"Lee","year":"2022","journal-title":"Diabetes Metab J"},{"key":"10.1053\/j.jrn.2026.03.003_bib9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4239\/wjd.v6.i2.326","article-title":"Role of oxidative stress in endothelial insulin resistance","volume":"6","author":"Paneni","year":"2015","journal-title":"World J Diabetes"},{"key":"10.1053\/j.jrn.2026.03.003_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/met.2008.0034","article-title":"The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects","volume":"6","author":"Simental-Mend\u00eda","year":"2008","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1053\/j.jrn.2026.03.003_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000528693","article-title":"Role of C-Reactive protein in kidney diseases","volume":"9","author":"Li","year":"2023","journal-title":"Kidney Dis"},{"key":"10.1053\/j.jrn.2026.03.003_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.905266","article-title":"A novel inflammation and insulin resistance related indicator to predict the survival of patients with cancer","volume":"13","author":"Ruan","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1053\/j.jrn.2026.03.003_bib13","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1080\/01635581.2023.2273577","article-title":"Value of C-Reactive protein-triglyceride glucose index in predicting cancer mortality in the general population: results from National Health and Nutrition Examination Survey","volume":"75","author":"Zhao","year":"2023","journal-title":"Nutr Cancer"},{"key":"10.1053\/j.jrn.2026.03.003_bib14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s12933-025-02960-w","article-title":"The relationship between C-reactive protein-triglyceride-glucose index and cardiovascular disease: insights from the China health and retirement longitudinal study (CHARLS)","volume":"24","author":"Zhang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1053\/j.jrn.2026.03.003_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1656187","article-title":"Association between C-reactive protein-triglyceride glucose index and all-cause mortality and premature death: a joint analysis based on case data from the Central Hospital of Shaoyang and CHARLS database","volume":"12","author":"Sun","year":"2025","journal-title":"Front Med"},{"key":"10.1053\/j.jrn.2026.03.003_bib16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12933-025-02686-9","article-title":"Association between C-reactive protein-triglyceride glucose index and stroke risk in different glycemic status: insights from the China Health and Retirement Longitudinal Study (CHARLS)","volume":"24","author":"Huo","year":"2025","journal-title":"Cardiovasc Diabetology"},{"key":"10.1053\/j.jrn.2026.03.003_bib17","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1186\/s12888-024-06336-4","article-title":"Association between C-reactive protein-triglyceride glucose index and depressive symptoms in American adults: results from the NHANES 2005 to 2010","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Psychiatry"},{"key":"10.1053\/j.jrn.2026.03.003_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/ije\/dys203","article-title":"Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS)","volume":"43","author":"Zhao","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1053\/j.jrn.2026.03.003_bib19","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1053\/j.jrn.2026.03.003_bib20","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7326\/0003-4819-154-9-201105030-00336","article-title":"Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-Drug combinations","volume":"154","author":"Bennett","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.jrn.2026.03.003_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018245","article-title":"Effects of SGLT2 inhibitors on cardiovascular outcomes and mortality in type 2 diabetes: a meta-analysis","volume":"98","author":"Zou","year":"2019","journal-title":"Medicine"},{"issue":"suppl_1","key":"10.1053\/j.jrn.2026.03.003_bib22","first-page":"S140","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in Diabetes\u20142023","volume":"46","author":"Elsayed","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1053\/j.jrn.2026.03.003_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet (London, England)"},{"key":"10.1053\/j.jrn.2026.03.003_bib24","doi-asserted-by":"crossref","first-page":"e1144","DOI":"10.1161\/CIR.0000000000000626","article-title":"Systematic review for the 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"139","author":"Wilson","year":"2019","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2026.03.003_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet (London, England)"},{"key":"10.1053\/j.jrn.2026.03.003_bib26","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMc1600827","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"374","author":"Sarafidis","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2026.03.003_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1475-2840-7-20","article-title":"Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment","volume":"7","author":"Farah","year":"2008","journal-title":"Cardiovasc Diabetol"},{"key":"10.1053\/j.jrn.2026.03.003_bib28","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1056\/NEJMoa1616011","article-title":"Liraglutide and renal outcomes in type 2 diabetes","volume":"377","author":"Mann","year":"2017","journal-title":"New Engl J Med"},{"key":"10.1053\/j.jrn.2026.03.003_bib29","article-title":"Long-term effect of sodium-glucose cotransporter 2 inhibitors in kidney functions: a systematic review and meta-analysis","volume":"104","author":"Zheng","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.jrn.2026.03.003_bib30","first-page":"2098","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Fern\u00e1ndez-Balsells","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2026.03.003_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.ajkd.2010.02.344","article-title":"Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates","volume":"56","author":"Horio","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2026.03.003_bib32","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2215\/CJN.18441120","article-title":"Association of depressive symptoms with rapid kidney function decline in adults with normal kidney function","volume":"16","author":"Zhang","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2026.03.003_bib33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.ajkd.2014.07.030","article-title":"GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US food and drug administration","volume":"64","author":"Levey","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2026.03.003_bib34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12933-025-02848-9","article-title":"C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: a nationwide prospective cohort study","volume":"24","author":"Ou","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1053\/j.jrn.2026.03.003_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1055\/a-2634-0157","article-title":"Relationship between the triglyceride-glucose index and chronic kidney disease: a meta-analysis of cohort studies","volume":"57","author":"Wang","year":"2025","journal-title":"Horm Metab Res"},{"key":"10.1053\/j.jrn.2026.03.003_bib36","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s10157-019-01729-2","article-title":"Triglyceride\u2013glucose index is a predictor of incident chronic kidney disease: a population-based longitudinal study","volume":"23","author":"Okamura","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"10.1053\/j.jrn.2026.03.003_bib37","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/jch.14913","article-title":"Association between triglyceride glucose index and chronic kidney disease in normal-weight Chinese adults with hypertension","volume":"26","author":"Yu","year":"2024","journal-title":"J Clin Hypertens"},{"key":"10.1053\/j.jrn.2026.03.003_bib38","doi-asserted-by":"crossref","DOI":"10.1177\/14791641221113784","article-title":"Triglyceride-glucose index is prospectively associated with chronic kidney disease progression in type 2 diabetes \u2013 mediation by pigment epithelium-derived factor","volume":"19","author":"Low","year":"2022","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1053\/j.jrn.2026.03.003_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12882-025-03984-w","article-title":"Association between triglyceride-glucose index and clinical outcomes among patients with chronic kidney disease: a meta-analysis","volume":"26","author":"Tuo","year":"2025","journal-title":"BMC Nephrol"},{"key":"10.1053\/j.jrn.2026.03.003_bib40","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.62347\/YRGD5457","article-title":"Clinical value of retinol binding protein, C-reactive protein and urine microalbumin in patients with chronic renal disease and ischemic cerebrovascular disease","volume":"16","author":"Wu","year":"2024","journal-title":"Am J Translational Res"},{"key":"10.1053\/j.jrn.2026.03.003_bib41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/nep.12841","article-title":"The association between c-reactive protein levels and the risk for chronic kidney disease hospitalizations in adults of a remote Indigenous Australian community \u2013 a prospective cohort study","volume":"22","author":"Arnold","year":"2017","journal-title":"Nephrology"},{"key":"10.1053\/j.jrn.2026.03.003_bib42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000355722","article-title":"Homocysteine and C-Reactive protein as useful surrogate markers for evaluating CKD risk in adults","volume":"37","author":"Chuang","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"10.1053\/j.jrn.2026.03.003_bib43","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1007\/s11357-015-9808-7","article-title":"Aging and low-grade inflammation reduce renal function in middle-aged and older adults in Japan and the USA","volume":"37","author":"Costello-White","year":"2015","journal-title":"Age"},{"key":"10.1053\/j.jrn.2026.03.003_bib44","doi-asserted-by":"crossref","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","article-title":"Insulin resistance in chronic kidney disease: a systematic review","volume":"311","author":"Spoto","year":"2016","journal-title":"Am J Physiology-Renal Physiol"},{"key":"10.1053\/j.jrn.2026.03.003_bib45","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1002\/j.2040-4603.2023.tb00281.x","article-title":"Insulin resistance and insulin handling in chronic kidney disease [M]","volume":"13","author":"Parvathareddy","year":"2023","journal-title":"Compr Physiol"},{"key":"10.1053\/j.jrn.2026.03.003_bib46","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.7150\/ijbs.62929","article-title":"Deletion of Smad3 protects against C-reactive protein-induced renal fibrosis and inflammation in obstructive nephropathy","volume":"17","author":"You","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1053\/j.jrn.2026.03.003_bib47","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/labinvest.2011.42","article-title":"C-reactive protein promotes acute renal inflammation and fibrosis in unilateral ureteral obstructive nephropathy in mice","volume":"91","author":"Li","year":"2011","journal-title":"Lab Invest"},{"key":"10.1053\/j.jrn.2026.03.003_bib48","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.kint.2016.06.010","article-title":"C-reactive protein promotes acute kidney injury via Smad3-dependent inhibition of CDK2\/cyclin E","volume":"90","author":"Lai","year":"2016","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2026.03.003_bib49","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1681\/ASN.2012040373","article-title":"NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury","volume":"23","author":"Nlandu","year":"2012","journal-title":"J Am Soc Nephrol : JASN"},{"key":"10.1053\/j.jrn.2026.03.003_bib50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000340033","article-title":"Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure","volume":"36","author":"Therrien","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.jrn.2026.03.003_bib51","first-page":"33","article-title":"Integration of ER stress, oxidative stress and the inflammatory response in health and disease","volume":"3","author":"Zhang","year":"2010","journal-title":"Int J Clin Exp Med"},{"key":"10.1053\/j.jrn.2026.03.003_bib52","doi-asserted-by":"crossref","DOI":"10.1186\/1476-9255-7-19","article-title":"Role of inflammation in t\u00fabulo-interstitial damage associated to obstructive nephropathy","volume":"7","author":"Grande","year":"2010","journal-title":"J Inflamm (London, England)"},{"key":"10.1053\/j.jrn.2026.03.003_bib53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00398.x","article-title":"Biomarkers of inflammation and progression of chronic kidney disease","volume":"68","author":"Tonelli","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2026.03.003_bib54","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1210\/jc.2015-2892","article-title":"Predictors of whole-body insulin sensitivity across ages and adiposity in adult humans","volume":"101","author":"Lalia","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.jrn.2026.03.003_bib55","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.3390\/ijms20184472","article-title":"Inflammaging and oxidative stress in human diseases: from molecular mechanisms to novel treatments","volume":"20","author":"Zuo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.jrn.2026.03.003_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12955-014-0109-0","article-title":"Is marital status associated with quality of life?","volume":"12","author":"Han","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"10.1053\/j.jrn.2026.03.003_bib57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/ije\/23.1.91","article-title":"Differences in self-reported morbidity by marital status and by living arrangement","volume":"23","author":"Joung","year":"1994","journal-title":"Int J Epidemiol"},{"key":"10.1053\/j.jrn.2026.03.003_bib58","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12933-025-02869-4","article-title":"Associations of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index with incident cardiovascular disease in middle-aged and older Chinese adults: a nationwide cohort study","volume":"24","author":"Ma","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1053\/j.jrn.2026.03.003_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2180373","article-title":"Inflammation-Related mechanisms in chronic kidney disease prediction, progression, and outcome","volume":"2018","author":"Mihai","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1053\/j.jrn.2026.03.003_bib60","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1186\/s12882-025-04613-2","article-title":"Association between the C-reactive protein-triglyceride-glucose index (CTI) and the risk of acute kidney injury in critically ill patients with cirrhosis","volume":"26","author":"Feng","year":"2025","journal-title":"BMC Nephrol"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105122762600052X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105122762600052X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:13:27Z","timestamp":1790723607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105122762600052X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S105122762600052X"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2026.03.003","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of C-Reactive Protein\u2013Triglyceride Glucose Index With Chronic Kidney Disease and Reduction of Renal Function","name":"articletitle","label":"Article Title"},{"value":"Journal of Renal Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jrn.2026.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the National Kidney Foundation, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}